Internal Medicine, Endocrinology, Diabetes, & Metabolism · Huntington, WV
NPI
1861606808
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1249 15th St, Suite 3000
Huntington, WV, 25701
Phone (304) 691-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
7,460 services
Medicare patients, 2024
554
Average age 67
Drug cost, 2024
$6.8M
18,777 prescriptions
Company payments, 2025
$3,655
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayman Elkadry was code 99214 (office e&m - established), 945 times for 346 patients. In total Ayman Elkadry billed 7,460 services in 65 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 945 | 346 | $99.05 | $94K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 841 | 164 | $45.81 | $39K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 553 | 137 | $36.15 | $20K |
| 82947 Clinical Chemistry | Office | 460 | 202 | $3.75 | $1,726 |
| 99457 E&M - Miscellaneous | Office | 380 | 101 | $37.80 | $14K |
| 99454 E&M - Miscellaneous | Office | 264 | 76 | $35.59 | $9,395 |
| 95251 Test - Miscellaneous | Office | 256 | 109 | $27.10 | $6,938 |
| 83036 Blood Count | Office | 211 | 152 | $9.39 | $1,981 |
| 99213 Office E&M - Established | Office | 100 | 77 | $66.82 | $6,682 |
| 96372 Injection Administration | Office | 84 | 40 | $11.19 | $940 |
| 76536 Ultrasound - Nonspecific | Office | 83 | 60 | $82.70 | $6,864 |
| 99453 E&M - Miscellaneous | Office | 82 | 82 | $15.42 | $1,265 |
| 99204 Office E&M - New | Office | 80 | 79 | $129.16 | $10K |
| 99203 Office E&M - New | Office | 63 | 63 | $73.74 | $4,646 |
| 95250 Test - Miscellaneous | Office | 60 | 58 | $108.73 | $6,524 |
By year: 2022 $194K for 10,572 services; 2023 $198K for 7,616 services; 2024 $235K for 7,460 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 460 | 202 | $3.75 | $1,726 |
| 83036 Blood Count | 211 | 152 | $9.39 | $1,981 |
| 87804 Immunoassay | 24 | 12 | $16.22 | $389 |
| 87426 Immunoassay | 20 | 20 | $34.62 | $692 |
| 81002 Clinical Chemistry | 12 | 11 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Ayman Elkadry prescribed most often to Medicare patients was Metformin Hcl, with 1,346 prescriptions and refills. In total Ayman Elkadry wrote 18,777 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 1,346 | 1,784 | 304 | $5,867 |
| Ozempic Semaglutide | 1,162 | 1,336 | 220 | $1.2M |
| Jardiance Empagliflozin | 1,099 | 1,328 | 228 | $761K |
| Levothyroxine Sodium Generic | 1,082 | 1,604 | 222 | $7,903 |
| Atorvastatin Calcium Generic | 1,052 | 1,528 | 278 | $6,504 |
| Trulicity Dulaglutide | 904 | 1,024 | 188 | $965K |
| Glimepiride Generic | 641 | 898 | 145 | $4,036 |
| Farxiga Dapagliflozin Propanediol | 604 | 749 | 144 | $415K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 568 | 1,067 | 174 | $75K |
| Mounjaro Tirzepatide | 480 | 524 | 88 | $533K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 477 | 739 | 168 | $35K |
| Januvia Sitagliptin Phosphate | 398 | 477 | 87 | $255K |
| Metformin Hcl Er Metformin Hcl | 374 | 563 | 83 | $3,247 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 356 | 467 | 107 | $12K |
| Lisinopril Generic | 344 | 544 | 98 | $1,514 |
Brand drugs: 8,550 claims; generic drugs: 8,045 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayman Elkadry $3,655 ($3,655 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbott Laboratories with $1,605.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 4 | $1,605 |
| Novo Nordisk Inc NVO | 11 | $432 |
| Senseonics, Incorporated SENS | 1 | $400 |
| Amgen Inc. AMGN | 10 | $251 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $162 |
| Medtronic, Inc. MDT | 2 | $149 |
| Sequel Med Tech, LLC | 1 | $124 |
| Madrigal Pharmaceuticals MDGL | 3 | $94.42 |
| Recordati_rare_diseases_inc. | 3 | $78.71 |
| Lilly USA, LLC LLY | 4 | $74.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.